Clinical Trial Update: Cardiotoxicity of Adjuvant Trastuzumab

View source ↗

Summary

Clinical trial update describing cardiotoxicity findings associated with adjuvant trastuzumab in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Heart Failure

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Royal Prince Alfred Hospital, Sydney, Australia | Conditions: Breast Neoplasms, Heart Failure | Status: COMPLETED